Friday, April 28, 2017 8:26:20 AM
Nasdaq will allow IFON to request a panel hearing which IFON will do. In that case, the hearing may occur 2,3,4 weeks from May 1. Until the hearing takes place, the stock will continue to trade. And, at the hearing, IFON may offer Nasdaq solutions (RS has to be one of them, but not the only one, imo) to comply. After that, the stock may continue to trade with or without RS!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM